Frequency of Urinary Tract Infections in Type 2 Diabetic Patients Taking Dapagliflozin.

Background Urinary tract infections (UTIs) are common in patients with diabetes. The use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) to achieve good glycemic control increases glucose levels in urine. This glycosuria further enhances the risk of UTIs.